Kennedy's controversial claims and proposed actions have negatively impacted pharmaceutical and biotech markets, causing a significant drop in shares. The concerns stem from his stance on vaccines, FDA regulations, and food safety measures, leading to uncertainty and skepticism among investors and analysts.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing